Abstract

Promyelocytic leukemia protein nuclear bodies (PML-NBs) are dynamic nuclear structures, shown to be important for herpesvirus replication; however, their role in regulating Marek’s disease virus (MDV) infection has not been studied. MDV is an oncogenic alphaherpesvirus that causes lymphoproliferative disease in chickens. MDV encodes a US3 serine/threonine protein kinase that is important for MDV replication and gene expression. In this study, we studied the role of MDV US3 in regulating PML-NBs. Using an immunofluorescence assay, we found that MDV US3 disrupts PML and SP100 in a kinase dependent manner. In addition, treatment with MG-132 (a proteasome inhibitor) could partially restore the levels of PML and SP100, suggesting that a cellular proteasome dependent degradation pathway is involved in MDV US3 induced disruption of PML and SP100. These findings provide the first evidence for the interplay between MDV proteins and PML-NBs.

Highlights

  • It has been reported that herpes simplex virus type 1 (HSV-1) encoded ICP0 protein contains an E3 ubiquitin ligase activity domain that could mediate the degradation of PML and SP100, and that this process is important for HSV-1 lytic replication and reactivation [7,8]; human cytomegalovirus (HCMV) encoded immediate early protein 1 (IE1) and IE2 have been shown to colocalize with and disrupt the PML-NBs, allowing for the efficient lytic replication of HCMV [9]; Epstein–Barr virus (EBV) encoded BZLF-1, a viral bZIP protein, has been reported to regulate virus replication by disrupting PML-NBs [10]; K-bZIP, encoded by Kaposi’s sarcoma-associated herpesvirus (KSHV), localizes to PML-NBs to establish virus replication compartments [11,12], and PML has been identified as a positive factor for KSHV lytic replication [13]

  • To better understand the interplay between Marek’s disease virus (MDV) proteins and PML-NBs, we examined the role of US3 from a very virulent plus MDV strain (686) in regulating the distribution and levels of PML-NBs components, PML and SP100

  • Our results show that the transfection of wild type US3 or kinase dead US3 (US3-K220A) did not affect the subcellular distribution of PML (Figure 1A) and SP100 (Figure 2A)

Read more

Summary

Introduction

The host utilizes various anti-viral mechanisms to limit virus replication and spread. Nuclear domain 10, known as promyelocytic leukemia protein nuclear bodies (PML-NBs), has been characterized as a host factor that restricts virus infection [1]. It has been reported that herpes simplex virus type 1 (HSV-1) encoded ICP0 protein contains an E3 ubiquitin ligase activity domain that could mediate the degradation of PML and SP100, and that this process is important for HSV-1 lytic replication and reactivation [7,8]; human cytomegalovirus (HCMV) encoded immediate early protein 1 (IE1) and IE2 have been shown to colocalize with and disrupt the PML-NBs, allowing for the efficient lytic replication of HCMV [9]; Epstein–Barr virus (EBV) encoded BZLF-1, a viral bZIP protein, has been reported to regulate virus replication by disrupting PML-NBs [10]; K-bZIP ( known as K8), encoded by Kaposi’s sarcoma-associated herpesvirus (KSHV), localizes to PML-NBs to establish virus replication compartments [11,12], and PML has been identified as a positive factor for KSHV lytic replication [13]. (GaHV-2), is an oncogenic and highly contagious avian alphaherpesvirus that causes T

Kaufer
Materials and Methods
Immunofluorescence Assay and Cells Counting
Statistical Analysis
Results and Discussion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.